1. Sherr CJ. Cancer cell cycles. Science 1996; 274 (5293): 1672-1677.

2. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML. Effects of Cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 2000; 60(2): 249-252.

3. Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, Frazier ML. Cyclin D1 polymorphism and in creased risk of colorectal cancer at young age. J Natl Cancer Inst 2001; 93(14): 1106-1108.

4. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H, Toku dome S. Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 2006; 132(3): 193-199.

5. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer 2006; 94(6): 928-934.

6. Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 2003; 290(21): 2843-2848.

7. Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, Fina MF, Roufail WM, Geisinger KR. Polymorphism of the Cyclin D1 Gene, CCND1 and risk for incident sporadic colorectal adenomas. Cancer Res 2003; 63(23): 8549-8553.

8. Huang WS, Tang R, Lin PY, Changchien CR, Chen JS, Chiang JM, Yeh CY, Wang JY, Hsieh LL. Impact of the Cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum 2006; 49(5): 602-608.

9. Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I, Maher ER. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002; 21(12): 1928-1933.

10. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11(5): 1005-1011.

11. Bala S, Peltomaki P. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 2001; 61(16): 6042-6045.

12. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003; 63 (21): 7056-7061.

13. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003; 278 (32):30339-30347.

14. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25(11): 1620-1628.

15. Knudsen KE. The cyclin D1b splice variant: an old oncogene learns new tricks. Cell Div 2006; 1:15

16. Hong Y, Eu KW, Seow-Choen F, Fook-Chong S, Cheah PY. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colo rectal cancer in patients in Singapore. Eur J Cancer 2005; 41(7): 1037-1044.

17. McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, Cassidy J, McLeod HL. Cyclin D1 protein expression and gene polymorphism in colorectal cancer Int J Cancer 2000; 88(1): 77-81.

18. Kruger S, Engelb C, Bier A, Mangold E, Pagen stecher C, Doeberitz MK, Holinski-Feder E, Moeslein G, Keller G, Kunstmann E, Friedl W, Plaschke J, Ruschoff J, Schackert HK. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett 2006; 236(2):191-197.

19. Stefanovska A-M, Josifovski T, Panovski M, Jasar D, Zografski G,Popevska Z, Efremov GD Dimovski AJ. G870A polymorphism in the cyclin D1 gene in colorectal cancer. Balkan J Med Genet 2002; 5(1&2): 27-30.

20. Sterjev Z, Josifovski T, Panovski M, Suturkova L, Dimovski AJ. The SULT1A1 allele with low potential for estrogen inactivation is associated with reduced colorectal cancer in postmenopausal women. Balkan J Med Genet 2005; 8(3&4): 43-48.

21. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Mus grove EA, Sutherland RL. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8(8): 2127-2133.

22. Butt AJ, McNeil CM, Musgrove EA, Sutherland RL. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endoc Relat Cancer 2005; 12(Suppl 1): S47-S59.

23. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG, Kushner PJ. Opposing action of estrogen receptors á and â on Cyclin D1 gene expression. J Biol Chem 2002;277(27): 24353-24360.

24. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M, Gustafsson J. Role of estrogen receptor â in colonic epithelium. Proc Natl Acad Sci USA 2006; 103(8):2959-2964.

25. Martineti V, Picariello L, Tognarini I, Carbonell Sala S, Gozzini A, Azzari C, Mavilia C, Tanini A, Fal chetti A, Fiorelli G, Tonelli F, Brandi ML. ERâ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer 2005; 12(2): 455-469.